Countries that are able should provide amphotericin B to Indian patients. The Global Action Fund for Fungal Infections (GAFFI) is calling on those with supplies of amphotericin B to provide them to India. In India, there are estimated to be over 4000 people with mucormycosis, (described as “black fungus” because it makes tissues go black)… Read more »
Following her pivotal role in GAFFI’s successful program in Guatemala, GAFFI has seconded Dr Ana Alastruey-Izquierdo to run its programs in Latin America and the Caribbean on a part-time basis. Ana is an accomplished scientist currently at Spain’s National Mycology Reference Laboratory at the Instituto de Salud Carlos III (ISCIII). In recent years, Ana has… Read more »
Leading global fungal infection charity GAFFI has issued guidelines to help patients and carers manage the condition Multiple reports from India have identified the otherwise rare fungal infection mucormycosis affecting many patients and leaving major disfigurement or death. High numbers have been seen in Gujrat, Maharastra, Karnataka, Tamil Nadu, Andhra Pradesh, Delhi, Chandigarh and Punjab… Read more »
On May 12th a special Webinar will be held to outline the new push to “end Cryptococcal Meningitis Deaths by 2030”, for people with advanced from HIV disease. The Special Webinar registration link is: https://mailchi.mp/salud.unm.edu/announcement-cdcchaiunitaid-global-webinar-series-ending-crytococcal-meningitis-deaths-by-2030-1568406 There are still too many people with undiagnosed and untreated or diagnosed but under-treated fungal meningitis in AIDS, especially in… Read more »
More than 300 million people worldwide suffer from serious fungal infections and around two million die each year. Research from The University of Manchester is improving patient survival and quality of life, from diagnosis though to drug development. The University of Manchester was the top ranked University in 2021 from The Times Higher Education Impact… Read more »
A fungal disease diagnostic and educational programme has had a transformational impact on the mortality of HIV patients in Guatemala, according to new research. The programme, say scientists at the Asociación de Salud Integral (ASI) in Guatemala City and The University of Manchester, will save lives in countries across the developing world if implemented. The… Read more »
Una nueva publicación alerta del impacto que ha tenido un programa de educación y diagnóstico de la enfermedad fúngica en la supervivencia de los pa cientes que viven con el HIV en Guatemala Científicos de la Asociación de Salud Integral (ASI) de la Ciudad de Guatemala y de la Universidad de Manchester afirman que… Read more »
GAFFI press release Following on from major steps forward since its inception in 2013, GAFFI has adjusted its strategy with a new emphasis on strong partnerships to: 1. Actively advocate for Essential Diagnostics and Antifungals to be accessible in each country as part of Universal Healthcare; 2. Empower and expand GAFFI’s Ambassadors, starting in Africa… Read more »
The 2021 list of new Fellows of the American Academy of Microbiology has included Professor David Denning. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, service and leadership in the microbial sciences. Election to the Academy is a mark of distinction. Nominated by Professor Neil Gow FRS… Read more »
You are invited to attend the following event: When: Jan 29, 2021 02:30 PM Amsterdam, Berlin, Rome, Stockholm, Vienna Topic: 3rd Essential Diagnostics’ List Launch Webinar Link: (Please register in advance for this webinar) https://who.zoom.us/webinar/register/WN_WXNKujhjQKGqLbTqa8RxEA WHO accepts rapid tests for life threatening fungal diseases aspergillosis and Pneumocystis pneumonia as ‘Essential Diagnostics’ The World Health Organisation,… Read more »
